Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study

Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is associated with psychological distress and a decrease of health-related quality of life (HRQoL), but lit...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvy, Marie, Kerckhove, Nicolas, Pereira, Bruno, Barreau, Fantine, Nguyen, Daniel, Busserolles, Jérôme, Giraudet, Fabrice, Cabrespine, Aurélie, Chaleteix, Carine, Soubrier, Martin, Bay, Jacques-Olivier, Lemal, Richard, Balayssac, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101543/
https://www.ncbi.nlm.nih.gov/pubmed/33967771
http://dx.doi.org/10.3389/fphar.2021.637593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101543/
https://www.ncbi.nlm.nih.gov/pubmed/33967771
http://dx.doi.org/10.3389/fphar.2021.637593

Ejemplares similares